The one-year price target for Calumet (NasdaqGS:CLMT) has been adjusted to $26.52 per share, marking a 38.67% increase from the previous estimate of $19.12. This revision was made on February 1, 2026, while the current average target represents a 10.41% decrease from the latest closing price of $29.60, with targets ranging from $19.19 to $34.65.
As of the latest report, 227 funds are holding positions in Calumet, down by 38 (14.34%) from the previous quarter. Institutional ownership has decreased by 2.22% to 47,443K shares, with an average portfolio weight of 0.24% dedicated to Calumet, an increase of 29.64%. The put/call ratio stands at 0.49, indicating a bullish market sentiment.
Among major stakeholders, Two Seas Capital increased its ownership to 6,976K shares (8.04%), a rise of 17.54%. Conversely, Wasserstein Debt Opportunities Management and Adams Asset Advisors reported decreases in their holdings, while Vanguard Total Stock Market Index Fund raised its allocation by 14.02% to 2,617K shares (3.02% ownership).
